NeuroOne files prospectus supplement for $13.4M equity offering

NeuroOne Medical Technologies filed a prospectus supplement dated June 12, 2026 for an ongoing $13.4M common stock offering under its Capital on Demand Sales Agreement with JonesTrading. The filing represents continued equity financing activity for the medical technology company.